Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low-Grade Serous Ovarian Cancer × Letrozole × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 21 Ovarian Neoplasms 16 Fallopian Tube Neoplasms 8 Recurrence 4 Breast Neoplasms 4 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Progesterone Resistance 2 Pancreatic Neoplasms 2 Endometrial Hyperplasia 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Peritoneal Neoplasms 1 Ovarian Cysts 1 Obesity 1 Neoplasms by Site 1 Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Leiomyosarcoma 1 Hydatidiform Mole 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Gestational Trophoblastic Disease 1 Endometrioid Endometrial Cancer 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

defactinib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06394804 2026-02-03

CHAMELEON

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Low-Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡